Sampling and full production runs are fundamentally different engagements in terms of cost, timeline, regulatory focus, and formula validation. A sample (or pilot batch) typically consists of 10–50 units produced at bench-scale or semi-automated conditions to allow you to test the formula's sensory properties (feel, smell, appearance), confirm the applicator fit and user experience, conduct internal stability spot-checks, and present the product to early customers or advisors for feedback. A full production run is 250–5,000+ units manufactured at the co-packer's full-scale facility, packaged identically to your final commercial product, and subjected to rigorous GMP protocols, stability testing, and regulatory compliance documentation. The sample is a prototype; the production run is the commercial product.
Sampling timelines are typically 2–6 weeks, compared to 10–16 weeks for a production run. The faster timeline is possible because sampling often skips full-length stability testing (you might conduct only a microbial viability snapshot at 0 and 4 weeks rather than 12-month real-time stability), uses pre-made containers and labels (off-the-shelf tubes with sticker labels rather than custom design), and leverages the co-packer's existing formula documentation rather than generating new batch records from scratch. However, sampling is not a free pass on quality; you should still request in-process testing (CFU count, pH, viscosity, preservative efficacy) to ensure the sample mirrors what you'll get at full production scale.
Sampling costs are lower per unit but higher in aggregate setup fees. A sample batch might cost $300–$800 in total (including co-packer time, raw materials, filling, and basic QC), which works out to $20–$50 per unit depending on whether you're sampling a pre-made formula or a custom-developed one. A full production run at 1,000 units costs $8,000–$25,000 in total (per-unit costs of $8–$25, as discussed in earlier answers), so the per-unit cost is actually lower once you scale up. This pricing structure incentivizes you to lock in your formula early and move to production, rather than iterating endlessly through samples. However, some brands find great value in sampling: you can test three different formula variants (single-strain, multi-strain, and enhanced with prebiotics) via sampling without committing $15,000+ to a full run, then select the winner and scale up.
Regulatory and documentation requirements differ between sampling and production. A sample does not require the full FDA compliance documentation, label approval, stability dossier, or master batch record that a production run does. You can often order a sample with a simple email authorization and verbal approval on formula. However, this informal approach can backfire: if your sample is fantastic but you later discover the co-packer's process documentation is sloppy or incomplete, you may struggle to replicate it at scale. Reputable co-packers will insist on basic documentation even for samples (a formula specification sheet, an ingredients list, and confirmation of preservative system) so that when you move to production, the batch record is already established and the transition is smooth. If a co-packer offers a sample with zero documentation, be wary—they may not have rigorous quality processes.
Stability considerations also shift between sampling and production. For a sample, you should request: (1) in-process CFU testing (immediate viability count after filling), (2) accelerated stability snapshot (storing a small portion at 40°C for 4 weeks and re-testing CFU), and (3) any informal sensory feedback (does the applicator dispense smoothly? Does the cream feel greasy or tacky?). For a production run, you must request: (1) CFU testing at release (to verify you're getting what the label claims), (2) real-time stability testing at 25°C and 2–8°C over 12 months (or your target shelf-life length), (3) full microbial challenge and preservation efficacy testing, and (4) batch-specific documentation (lot number, manufacturing date, stability protocol) that supports your label claim and provides evidence in case of a recall or FDA inspection. Sampling lets you de-risk formula sensory and basic viability; production lets you de-risk regulatory and long-term efficacy claims.
The relationship between sampling and production also depends on whether the formula is proprietary to you or pre-made by the co-packer. If you've developed your own formula (e.g., a custom strain blend with prebiotics), sampling is essential to confirm the co-packer can execute it at the batch-size you've specified. If you're using a co-packer's pre-made, off-the-shelf vaginal probiotic cream formula, sampling may be skipped entirely—the co-packer already has 12+ months of stability data, the formula is proven, and you move directly to production. This is why many new brands opt for a pre-made formula on a short timeline: 250–500 unit MOQs, 8–10 week lead times, and no sampling phase.
Common mistake #1: Skipping sampling and moving directly to a large production run (1,500–2,000 units) because you want to minimize time-to-market. If the formula has an unexpected issue (e.g., the applicator is too stiff to dispense, or the cream separates within two weeks), you're stuck with thousands of unsellable units and a $20,000+ loss. Sampling a 50-unit batch for $500 seems slow, but it saves you from a catastrophic scale-up mistake.
Common mistake #2: Assuming a sample will behave identically to a full production run. Samples are often made by hand or on a small mixer, which can affect emulsion structure, CFU distribution, and fill consistency compared to large-scale automated filling. When you move from sample to production, the product may look or perform slightly differently. Reputable co-packers will prepare samples using the same equipment and processes as full production (just in smaller batches) to ensure continuity. If a co-packer says "we make samples by hand and then switch to automated filling for production," request that they prepare your sample on the same automated line you'll use at production scale, even if it costs slightly more.
Common mistake #3: Not requesting stability data from samples. Even a 4-week accelerated test (storing the sample at 40°C) is valuable; it gives you a rough sense of whether CFU counts are holding or crashing. If your sample shows CFU dropping 40% in 4 weeks at 40°C, you can flag this with the co-packer and adjust the formula (e.g., improve the oxygen barrier, switch preservatives, add antioxidants) before committing to a full run. Ignoring this signal risks launching a product with short shelf life and poor customer reviews.
Best practice: Order a 50–100 unit sample of your target formula and packaging, request in-process CFU testing and a 4-week accelerated stability snapshot, and review the results with the co-packer before signing a production contract. This adds 3–4 weeks to your overall timeline but dramatically reduces the risk of a failed full-scale run. Many successful brands do this: they iterate through one or two samples, refine the formula and packaging, then scale to production with confidence. When requesting a sample quote via AJ Cosmo Labs, ask the co-packer upfront if they can provide in-process testing and accelerated stability data as part of the sample engagement, and ask what the cost adder is. This signals you're a serious, quality-focused founder and sets expectations for both parties.
Read the full guide on Private Label Vaginal Probiotic Cream Manufacturer Low MOQ →